[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337208-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337208-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-a-novel-immune-checkpoint-related-gene-signature-predicts-prognosis-and-immunotherapy-in-breast-cancer-and-experiment-verification","Identification of a novel immune checkpoint-related gene signature predicts prognosis and immunotherapy in breast cancer and experiment verification","","Study identifies immune checkpoint-related differentially expressed genes in breast cancer (BRCA) and normal tissues using TCGA, then builds a 7-gene immune checkpoint-related signature via univariate Cox regression with LASSO Cox modeling. A nomogram quantifies prognostic significance and links the risk model to clinical indicators, tumor microenvironment features, immune cell infiltration, immune response, and drug susceptibility. GO/KEGG and GSEA characterize enriched immune processes, while in vitro cell assays validate the role of MAP2K6 in BRCA proliferation, invasion, migration, colony formation, and apoptosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-a-novel-immune-checkpoint-related-gene-signature-predicts-prognosis-and-immunotherapy-in-breast-cancer-and-experiment-verification/337208/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-a-novel-immune-checkpoint-related-gene-signature-predicts-prognosis-and-immunotherapy-in-breast-cancer-and-experiment-verification/337208.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-22","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How is the prognostic gene risk model constructed?","Question",{"text":63,"@type":64},"Immune checkpoint-related differentially expressed genes are identified from TCGA, then a 7-gene signature is built using univariate Cox regression combined with LASSO Cox regression. A nomogram is further used to predict prognostic significance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What do the high-risk and low-risk groups represent clinically?",{"text":68,"@type":64},"Patients are divided into high- and low-risk groups based on the median risk score. High-risk BRCA patients show poorer overall survival and distinct differences in clinicopathological features, tumor microenvironment, immune cell infiltration, immune response, and drug susceptibility.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports the role of MAP2K6?",{"text":72,"@type":64},"In vitro cell assays evaluate MAP2K6 effects on BRCA cell proliferation, invasion, migration, colony formation, and apoptosis rate. Results suggest MAP2K6 may play a pivotal role in initiation and progression, consistent with a tumor suppressor function.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337208,1790146335,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIdentification of a novel immune checkpoint-related gene signature predicts prognosis and immunotherapy in breast cancer and experiment verification  \nKeYin1,4, Yangyang Guo1,4, Jinqiu Wang1, Shenchao Guo1, Chunxu Zhang1, Yongping Dai1􀀍, Yu Guo1􀀍 & Chen Dai2,3􀀍  \nBreast cancer (BRCA) is one of the pivotal causes of female death worldwide. And the morbidity and mortality of breast cancer have increased rapidly. Immune checkpoints are important to maintain immune tolerance and are regarded as important therapeutic targets. However, research for BRCA were limited to single immune checkpoint-related gene (ICG) and few studies have systematically explored expression profile of Immune checkpoint-related genes or attempted to construct a prognostic gene risk model based on immune checkpoint-related genes. We identified immune checkpoint-related differentially expressed genes (DEGs) in BRCA and normal breast tissues from TCGA database. A 7-gene signature was created by utilizing the univariate Cox regression model with least absolute shrinkage and selection operator (LASSO) Cox regression method. In addition, we conducted a nomogram to predict the prognostic significance. This tool enables quantitative prediction of patient prognosis, serving as a valuable reference for clinical decision-making, thereby improving patient outcomes. Relationships between our risk model and clinical indicators, TME (Tumor Microenvironment), immune cell infiltration, immune response and drug susceptibility were investigated. A set of in vitro cell assays was conducted to decipher the relationship between MAP2K6 and proliferation, invasion, migration, colony formation and apoptosis rate of breast cancer cells. Asa result, we established a prognostic model composed of seven ICGs in BRCA. Based on the median risk score, BRCA patients were equally assigned into two groups of high-and low-risk. High-risk BRCA patients have poorer OS (overall survival) than low-risk patients. In addition, there were remarkable differences between these two groups in clinicopathological features, TME, immune cell infiltration, immune response and drug susceptibility. The results of GO and KEGG analyses indicated that DEGs between the high-and low-risk groups were involved in immune-related biological processes and pathways. GSEA analysis also showed that a number of immune-related pathways were notably enriched in the low-risk group. Finally, results of cell-based assays indicated that MAP2K6 may play a pivotal role in the initiation and progression of breast cancer as a tumor suppressor gene. In conclusion, we created a novel ICG signature that has the potential to predict the survival and drug sensitivity of BRCA patients. Furthermore, this study indicated that MAP2K6 may serve as a novel target for BRCA therapy.  \nKeywords BRCA, Immune checkpoint, Prognosis, Immune cell infiltration, Drug susceptibility, Cell experiments  \nAbbreviations  \n1Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.  \n2Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China. 3Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-Sen University, No. 628 Zhenyuan Road, Shenzhen 518107, Guangdong, China. 4Ke Yin, Yangyang Guo, have contributed equally to this work. 􀀍 email: [dypnbyy@163.com](dypnbyy@163.com); [guoyu308@163.com](guoyu308@163.com); [daichen0408@126.com](daichen0408@126.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nGO  \nKEGG  \nGSEA  \nDEGs  \nCDF  \nKM  \nTME  \nTMB  \nMSI  \nMSSMSI-H  \nMSI-LPCAt-SNEOxa  \nBATF MAP2K6 NFKBIE PAKs  \nGene ontology  \nKyoto encyclopedia of genes and genomes Gene set enrichment analysis Differentially expressed genes Cumulative distribution function Kaplan Meier  \nTumor microenvironment Tum","cbCaipYvuptfgZTI","https://ap.wps.com/l/cbCaipYvuptfgZTI","pdf",21571145,21,"English","# Overview\n## Immune checkpoint genes and rationale\n## Data sources and differential expression\n## Model construction and prognostic tools\n## Risk groups and associations\n## Functional enrichment analyses\n## Experimental verification\n## Conclusions","[{\"question\":\"How is the prognostic gene risk model constructed?\",\"answer\":\"Immune checkpoint-related differentially expressed genes are identified from TCGA, then a 7-gene signature is built using univariate Cox regression combined with LASSO Cox regression. A nomogram is further used to predict prognostic significance.\"},{\"question\":\"What do the high-risk and low-risk groups represent clinically?\",\"answer\":\"Patients are divided into high- and low-risk groups based on the median risk score. High-risk BRCA patients show poorer overall survival and distinct differences in clinicopathological features, tumor microenvironment, immune cell infiltration, immune response, and drug susceptibility.\"},{\"question\":\"What experimental evidence supports the role of MAP2K6?\",\"answer\":\"In vitro cell assays evaluate MAP2K6 effects on BRCA cell proliferation, invasion, migration, colony formation, and apoptosis rate. Results suggest MAP2K6 may play a pivotal role in initiation and progression, consistent with a tumor suppressor function.\"}]","Identification of a novel immune checkpoint-related gene signature predicts prognosis and immunotherapy in breast cancer and experiment verification | PDF",1790018149,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc53103b943b0a2305aba06208fdd400.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce147f449073b6dcfa60f3c11eeca5b5.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc9f20e2eb11c620cb5621e844319aed.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d6de29173aba5581301b5ff1c649ea0.webp",980,1287]